CTNNB1 and hepatocellular adenoma: In addition, it also shows that in some rare cases of HCA (i.e., FAP-HCA), strong overexpression of GS alone does not allow to ascribe a HCA to the subtype of beta-catenin-activated HCA and may not necessarily demonstrate an increased risk of malignant transformation.